The short version
18 companies supply this market — deep enough that no single failure threatens the supply.
Market view
ondansetron hydrochloride · Powder
38 marketed package NDCs · 18 active manufacturers
Most dispensed: 8 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle · 4 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle · 2 mg/mL · Injection · #25 vials/tray / 2 ml in 1 vial · 4 mg · Tablet, Film Coated · #500 tablet, film coateds/bottle
What changed in the last 90 days
Every detected change for ondansetron hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Ondansetron HydrochlorideAug 19, 2026Price downNADAC $0.08451 → $0.08122 per unit (-3.89%)
- Ondansetron HydrochlorideAug 19, 2026Price downNADAC $0.06125 → $0.05966 per unit (-2.6%)
- Ondansetron HydrochlorideAug 19, 2026Price downNADAC $0.08451 → $0.08122 per unit (-3.89%)
- Ondansetron HydrochlorideAug 19, 2026Price downNADAC $0.08451 → $0.08122 per unit (-3.89%)
- Ondansetron HydrochlorideAug 19, 2026Price downNADAC $0.06125 → $0.05966 per unit (-2.6%)
- Ondansetron HydrochlorideAug 19, 2026Price downNADAC $0.06125 → $0.05966 per unit (-2.6%)
- OndansetronAug 19, 2026Price downNADAC $0.17917 → $0.1771 per unit (-1.16%)
- OndansetronAug 19, 2026Price downNADAC $0.17281 → $0.16997 per unit (-1.64%)
- OndansetronAug 19, 2026Price downNADAC $0.17917 → $0.1771 per unit (-1.16%)
- Ondansetron HydrochlorideAug 19, 2026Price downNADAC $0.08451 → $0.08122 per unit (-3.89%)
Same drug class
Other molecules FDA puts in Serotonin-3 Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- fosnetupitant and palonosetron· 1 maker
- netupitant and palonosetron· 1 maker
- ondansetron tablets· 1 maker
- alosetron· 2 makers
- ondansetron hcl· 2 makers
- palonosetron· 5 makers
- alosetron hydrochloride· 8 makers
- granisetron· 8 makers
- granisetron hydrochloride· 15 makers
- palonosetron hydrochloride· 26 makers
- ondansetron· 63 makers
Common questions
- Is Ondansetron hydrochloride in shortage right now?
- No. FDA does not currently list Ondansetron hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ondansetron hydrochloride?
- 61 companies have marketed Ondansetron hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Ondansetron hydrochloride cost?
- The typical pharmacy pays about $0.0812 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.